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Background/aim: Polycystic ovarian syndrome (PCOS) is one of the most common causes of infertility. One of the best therapeutic
options for PCOS patients is intracytoplasmic sperm injection (ICSI). In vitro maturation (IVM) can also be a useful technique for these
women. The goal of this study was to evaluate both the zona pellucida (ZP) birefringence and meiotic spindle (MS) of in vivo- and in
vitro-matured oocytes from PCOS patients using the PolScope system.
Materials and methods: Immature oocytes undergoing IVM and MII oocytes were obtained from PCOS patients in an ICSI program.
Using PolScope, the presence of MS and ZP birefringence was assessed in both in vivo-matured oocytes (n = 32) and IVM oocytes (n =
24). Oocytes were classified as having highly birefringent (HB) ZP and lowly birefringent (LB) ZP. Furthermore, the rates of fertilization
after ICSI were evaluated.
Results: The maturation rate was 68.5% after IVM. The percentage of a HB-ZP was significantly higher in the IVM oocytes than in vivomatured ones (58.3% vs. 31.2%, respectively; P = 0.04). There were similar outcomes for the fertilization rates and MS detection between
the two groups (P = 0.80 and P = 0.53, respectively).
Conclusion: Clinical IVM is a safe technology for the maturation and maintenance of oocyte integrity in PCOS patients. The use of the
noninvasive PolScope is recommended for detection of healthy oocytes in ICSI.
Key words: Polycystic ovarian syndrome, in vitro maturation, zona pellucida birefringence, meiotic spindle, fertilization

1. Introduction
Polycystic ovarian syndrome (PCOS) is one of the most
common causes of infertility in women of reproductive age
(1). PCOS is characterized by menstrual cycle irregularity,
chronic anovulation, ovarian polycystic morphology on
ultrasound, and hyperandrogenemia (2,3). Currently, there
are several therapeutic options for infertile women with
PCOS, one of which is intracytoplasmic sperm injection
(ICSI) following controlled ovarian hyperstimulation
(COH). Hence, by using COH multifollicular recruitment
and retrieval of immature oocytes with subsequent
application of in vitro maturation (IVM) technology, the
number of matured oocytes can be increased for ICSI
programs (4,5).
IVM can be a useful technique for women with PCOS
who are at the risk of ovarian hyperstimulation syndrome
(OHSS) (6,7). OHSS is one of the disadvantages of ovarian
stimulation with large doses of gonadotropins, which
is unnecessary for IVM (8,9). On the other hand, the
* Correspondence: khalili59@hotmail.com
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oocyte quality is the determining factor for the outcome of
assisted reproductive technology (ART) cycles (10). It has
been confirmed that assessment of the zona pellucida (ZP)
birefringence and meiotic spindle (MS) using PolScope
could be helpful to select suitable oocytes for ICSI without
negative effects on matured oocytes. The PolScope system
is recommended to assess the MS in order to decrease
spindle damages during sperm injection (5).
Spindles are subcellular structures that are present
in matured oocytes and composed of microtubules.
Disturbance of the MS can directly affect the development
of embryo, due to abnormal chromosome alignment
leading to polyploidy and aneuploidy. By definition,
MS microtubules are essential organelles of oocytes.
However, they are sensitive to chemical and physical
changes, such as temperature and culture conditions
(5,11). The ZP is another birefringent structure that could
be assessed by PolScope as a reliable marker of oocyte
quality and subsequent ART outcomes. The ZP is a unique
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extracellular coat composed of filaments that are organized
in a three-dimensional network structure surrounding
maturing oocytes during ovulation and fertilization, up to
embryonic development. Currently, software programs are
available that automatically analyze the inner layer of ZP
birefringence scores, relying on intensity and distribution
of the birefringence (5,12). Therefore, the objective of the
present study was to compare the MS and ZP birefringences
of both in vivo- and in vitro-matured oocytes from PCOS
patients undergoing an ICSI program.
2. Materials and methods
2.1. Stimulation protocol and oocyte collection
The oocytes were collected from PCOS patients admitted
to the Research and Clinical Center for Infertility, Yazd,
Iran. Their ages ranged from 22 to 39 years (mean age ±
SD: 29.64 ± 5.31 years). Each patient provided written
informed consent before the treatment. An independent
ethics committee in our institute approved the study.
Briefly, pituitary downregulation using an exogenous
GnRH agonist or antagonist was started. Ovaries were
then stimulated with follicle-stimulating hormone (FSH;
Ferring Co., Germany). By monitoring, when two or more
follicles measuring ≥18 mm in diameter were observed on
transvaginal ultrasound, recombinant hCG (rhCG; IBSA
Co., Switzerland) was administered, and 36 h later oocyte
retrieval was performed by transvaginal ultrasonographyguided aspiration.
2.2. Oocyte preparation
All cumulus–oocyte complexes (COCs) were incubated
for 2–3 h in culture medium (G-IVF; Vitrolife, Sweden)
at 37 °C and 6% CO2. The cumulus and coronal cells were
removed by 30–60 s of exposure to 80 IU/mL hyaluronidase
(Irvine Scientific, USA) and by pipetting the COCs with
a pasture pipette. The denuded oocytes were classified
according to their stage of maturation. Based on extrusion
of the first polar body (PB), oocytes were considered as
mature (MII) and used for ICSI procedures, and immature
oocytes underwent IVM.
2.3. IVM procedures
Initially, immature oocytes were classified as GV- or
MI-stage. Then they were washed in 3 drops of washing
medium (SAGE IVF) and cultured in maturation medium
(SAGE, USA) supplemented with 75 mIU/mL FSH
and 75 mIU/mL LH (Ferring, Germany) at 37 °C in an
incubator under 5% CO2 and 95% air with high humidity.
Nuclear maturation was evaluated after 24 and 48 h using
a stereoscope (Olympus, Japan).
2.4. Spindle and ZP birefringence examination
For imaging spindles and ZP birefringence, each mature
oocyte was placed individually in an equilibrated 3-mL
droplet of buffered medium (G-Mops-V1; Vitrolife)

in a glass-bottomed culture dish (WillCo-Dish; Bellco
Glass, USA). Oocytes were immediately imaged under a
polarizing optical system (OCTAX PolarAIDE; Octax,
Germany), then detection of the MS and homogeny of the
inner layer of the ZP was done. In this manner, oocytes
were classified as having high ZP birefringence with a
score of ≥10 and low ZP birefringence with a score of <10.
2.5. ICSI procedure
ICSI was performed according to the methodology
described by Khalili et al. (13). Before the microinjection,
oocytes were incubated for 3 h and then denudation from
cumulus cells occurred using 80 IU/mL hyaluronidase
(Sigma Chemical Co., USA) along with the mechanical
aid of Pasteur pipettes. Each MII oocyte was washed in
culture media and then their maturity was evaluated using
an inverted microscope (Nikon TE300, Japan). Following
semen analysis and sperm preparation, the motile
spermatozoa were placed in 10% polyvinylpyrrolidone
solution (PVP) droplets (Irvine Scientific) and the best
morphologically spermatozoa were selected for the
microinjection procedure. The injected oocytes were
washed twice and placed individually in fresh droplets of
G1 (Vitrolife) covered with mineral oil (ReproLine Co.,
Germany).
Fertilization was evaluated 16–18 h after ICSI under an
inverted microscope (TE300; Nikon, Japan) and injected
oocytes checked for the presence of two pronuclei (2PN)
and a second PB were considered to be normal. Unfertilized
oocytes were incubated longer and checked again.
2.6. Statistical analysis
Statistical analysis was carried out using chi-square and
Fisher exact tests. Data were presented as mean ± SD and
as odds ratios (ORs) and 95% confidence intervals (95%
CIs). Data were analyzed using SPSS 20 (IBM Corp., USA).
Statistical significance was set at P < 0.05.
3. Results
In all, 158 oocytes were retrieved from 11 patients, of
which 123 (77.8%) were MII, whereas 30 (18.9%) and 5
(3.1%) were GV and MI oocytes, respectively. After 24–48
h of in vitro culture, 24 (68.5%) oocytes extruded the first
PB and reached the MII stage. Thirty-two in vivo-matured
oocytes from PCOS patients were compared with IVM
oocytes. When the oocytes were examined with PolScope,
the percentage highly birefringent ZP was higher in the
IVM than the in vivo-matured group (58.3% vs. 31.2%,
respectively; P = 0.04). A birefringent spindle was detected
in 21.9% of in vivo-matured MII oocytes compared with
29.2% of IVM MII oocytes (P = 0.53; Table; Figure). After
ICSI, the rate of fertilization achieved by in vivo-matured
oocytes (65.6%) was slightly higher than the rate for IVM
ones (62.5%), but the difference was insignificant (P =
0.81).
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Table. ZP birefringence/spindle visualization and fertilization rates in in vivo- and in vitro-matured oocytes from PCOS patients.
In vivo

In vitro

n

%

n

High

10

31.2

14

Low

22

68.8

10

41.7

ZP birefringence

%
58.3

Odds ratio (95% CI)

P

0.32 (0.10–0.97)

0.043

1.47 (0.43–4.95)

0.533

0.87 (0.29–2.62)

0.809

Spindle visualization
Visible

7

21.9

7

29.2

Not visible

25

78.1

17

70.8

Fertilized

21

65.6

15

62.5

Unfertilized

11

34.4

9

37.5

Fertilization rate

Figure. PolScope (OCTAX PolarAID; Octax, Herbon,
Germany) image of an IVM human oocyte. A bright meiotic
spindle (arrow) is clearly visible (40× magnification).

4. Discussion
To date, PCOS is one of the most prevalent causes of
infertility in women of childbearing age. In this study,
the majority of patients with PCOS were younger than
35 years (86.6%). Although PCOS patients could benefit
from ART, which includes direct manipulation of gametes,
several days of treatment are required with gonadotropin
to achieve pregnancy. In general, 15%–20% of the oocytes
collected in ART cycles are immature (14,15). It has been
reported that IVM of these immature oocytes is a potentially
useful treatment for increasing the number of embryos,
especially in poor responders, such as PCOS patients (16).
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Therefore, most notably PCOS patients might benefit
from emerging IVM technologies and abbreviated COH
protocols (9). The first pregnancy and delivery of a healthy
baby after IVM obtained from an anovulatory woman
with PCOS was reported by Trounson et al. in 1994 (17).
In the present study, the oocyte maturation rate after IVM
in PCOS patients undergoing oocyte retrieval for ICSI was
68.5%. However, Child et al. showed that the maturation
rate of immature oocytes retrieved during an unstimulated
cycle from women with PCOS was as high as 76% (18).
In another study by Du et al., the oocyte maturation
percentage from nonstimulated cycles in PCOS cases was
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only 63%. They concluded that application of the IVM
method in the treatment of infertility could be offered as
an alternative to conventional IVF (19). It was reported
that FSH priming before retrieval of immature oocytes
from patients with PCOS could improve the maturational
potential of the oocytes but did not increase the number
of oocytes harvested from the patient (20). Those results
are consistent with a previous study by Cha and Chian
(21) that showed that, when oocytes were obtained from
stimulated cycles, germinal vesicle breakdown (GVBD)
was observed after 30 h of in vitro culture compared with
oocytes obtained from unstimulated cycles where GVBD
was seen after 48 h. In addition, Barnes et al. (22) compared
the maturation and fertilization rates of immature oocytes
selected from two different groups including women with
normal ovaries and PCOS patients in an unstimulated
cycle, and they found these parameters to be significantly
higher in the normal group compared to PCOS patients.
The present study evaluated the developmental competence
of in vivo- and in vitro-matured oocytes of PCOS patients
undergoing an ICSI program. In our experience, the
rates of fertilization after ICSI did not differ significantly
between the two groups.
The MS is a dynamic structure during meiosis (23) and
damage to the metaphase spindle may happen in some
oocytes during sperm injection if the spindles are away
from the first PB (24). It was suggested that the presence of
a birefringent spindle in MII oocytes could predict a higher
fertilization rate and embryo developmental competence
after ICSI (25). It is also well recognized that the spindle
and chromosomes have critical importance in fertilization
and subsequent embryo development (26). Therefore,
spindle imaging could help to identify abnormalities in
the oocyte MS (27). Li et al. analyzed the MS via staining
by immunocytochemistry. Spindles were observed in 75%
of their IVM oocytes and in 81.5% of oocytes matured in
vivo. They also found that the rate of spindle abnormality in
IVM oocytes was higher compared with those matured in
vivo. However, these oocytes retrieved from stimulated and
unstimulated ovaries of infertile women with PCOS and
their data suggested that IVM could play a deleterious role
in MS and chromosome arrangements (26). There are many
reports about the sensitivity of spindles to environmental
factors (27–29). Some authors reported high rates of
abnormal chromosomes in human oocytes following IVM
(30–32). Data generated from this study showed that the
percentage of oocytes in which a birefringence spindle was
detected was insignificantly higher in the IVM group when
compared with in vivo-matured oocytes. Moreover, Omidi
et al. and Rienzi et al. reported that the rate of spindle
presentation in IVM oocytes was lower than in oocytes
matured in vivo (5,33). In the last decade, visualization
of ZP-BF by using PolScope has been recognized as a
noninvasive test of oocyte quality. The ZP is a multilaminar

glycoprotein coat that forms during oogenesis (34,35). At
the molecular level, the ZP is composed of three layers
that are composed of 4 protein filaments, ZP1, ZP2, ZP3,
and ZP4 (12). However, the inner layer exhibits maximum
birefringence with application of the PolScope (36).
Birefringence is one of the properties of the human ZP
that have been suggested as a marker of oocyte quality and
can indicate the formation of the ZP during maturation to
MII. Different culture conditions may also affect the ZP
architecture (37,38). We hypothesized that the zona with
high-order structured fibers might reflect the healthiness
of an oocyte and its full oocyte maturation (nuclear and
cytoplasmic) (12). In addition, in that study we observed
that the percentage of a HB-ZP was significantly higher
in the IVM oocytes than in vivo-matured ones, similar to
findings reported by Omidi et al. According to Braga et al.
and Petersen et al. (12,37), the ZP birefringence is unaffected
during IVM, and these findings confirm our results. We
also observed that the fertilization rate after sperm injection
(62.5%) in IVM oocytes was similar to those reported by
earlier authors (39,40).
We used ICSI for fertilization of in vitro- or in vivomatured oocytes and similar fertilization rates were
observed between the two groups. It was reported
that women with PCOS have low quality oocytes and
fertilization rates compared to other infertile women
(41,42). Another study by Ebner et al. showed that
there was a positive correlation between high/positive
ZP birefringence scores and blastocyst formation, but
not embryo quality or pregnancy (43). Using a different
technique (intensity of the zona inner layer retardance),
Raju et al. observed that when the retardance of the ZP
inner layer was >3 nm the rate of embryonic development
to the blastocyst stage was higher compared to oocytes
with retardance of <3 nm (11). Another study reported
that there were no differences in the pregnancy rates of
in vivo-matured oocytes and IVM oocytes (2), and their
findings are similar to our results. In similar study, Child
et al. reported insignificant differences between the rates
of fertilization and embryo cleavage when oocytes were
matured in vitro or in vivo (18).
In conclusion, an absence of a relationship was
recognized between in vitro nuclear and cytoplasmic
maturation of oocytes from stimulated PCOS patients
and deleterious effects on ZP birefringence and MS
visualization. To our knowledge, clinical IVM combined
with PolScope technology may be safely used for both
maturation and visualization of oocyte integrity in ICSI
programs for PCOS patients.
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